Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,601–1,700 of 2,883
Glucose Metabolism and Aging of Hematopoietic Stem and Progenitor Cells
Poisa-Beiro, L., Landry, J. J. M., Raffel, S., Tanaka, M., Zaugg, J. B., Gavin, A., & Ho, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063028 · Cited by 15
DNA damage in protective and adverse inflammatory responses: Friend of foe?
Poliezhaieva, T., & Ermolaeva, M. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.06.004 · Cited by 17
Chen, L., Gao, C., Yin, X., Mo, L., Cheng, X., Chen, H., Jiang, C., Wu, B., Zhao, Y., Li, H., et al. (2024) · MedComm · doi:10.1002/mco2.742 · Cited by 18
“14,15 Importantly, studies have shown that removing p16-positive cells in aged mice improved glomerulosclerosis, 16 and knockout of p21 or p27 in T1D mice alleviated proteinuria and glomerular dilation.”
BackgroundClinical Implications of Cellular Senescence on Wound Healing
Resnik, S. G., Egger, A. N., Abujamra, B. A., & Jozic, I. (2020) · Current Dermatology Reports · doi:10.1007/s13671-020-00320-3 · Cited by 18
Vascular Diseases and Gangliosides
Sasaki, N., & Toyoda, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246362 · Cited by 17
Shyu, Y., Liao, P.-C., Huang, T., Yang, C., Lu, M., Huang, S., Lin, X., Liou, C., Kao, Y.-J., Lu, C.-H., et al. (2022) · Advanced Science · doi:10.1002/advs.202201409 · Cited by 16
Galactose-modified duocarmycin prodrugs as senolytics
(2019) · doi:10.1101/746669 · Cited by 172
Otoda, T., Aihara, K., & Takayama, T. (2025) · Biomedicines · doi:10.3390/biomedicines13051053 · Cited by 14
“Recent evidence suggests that eliminating senescent cells alleviates age-related conditions, including atherosclerosis and chronic kidney disease, while extending the health span of animal models [109].”
CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases
Yang, Z., Liu, Y., & Hai, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122556 · Cited by 16
Effects of lifespan-extending interventions on cognitive healthspan
Čulig, L., Sahbaz, B. D., & Bohr, V. A. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.36 · Cited by 14
Cell Senescence, Telomerase, and Senolytic Therapy
Fossel, M. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1901034 · Cited by 14
Kuehnemann, C., Hu, K., Butera, K., Patel, S. K., Bons, J., Schilling, B., Aguayo‐Mazzucato, C., & Wiley, C. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.935106 · Cited by 20
Oyama, K., Iwagami, Y., Kobayashi, S., Sasaki, K., Yamada, D., Tomimaru, Y., Noda, T., Asaoka, T., Takahashi, H., Tanemura, M., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34725 · Cited by 18
“2 Senescent cells play a crucial role in premature and natural aging 3 and age-related diseases.”
BackgroundTherapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks
Mallikarjun, V., & Swift, J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.020 · Cited by 14
Senotherapy for chronic lung disease
Barnes, P. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100069 · Cited by 18
“Using a caspase-dependent mechanism to eliminate p16 INK4a cells results in a more than 30% extension in lifespan in naturally aging mice due to reduced organ failure and cancer development (Baker et al, 2016a).”
Zhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.01.001 · Cited by 22
p19Arf Exacerbates Cigarette Smoke-Induced Pulmonary Dysfunction
Mikawa, R., Sato, T., Suzuki, Y., Baskoro, H., Kawaguchi, K., & Sugimoto, M. (2020) · Biomolecules · doi:10.3390/biom10030462 · Cited by 15
Advances in Nanotherapy for Targeting Senescent Cells
Shi, Y., Zhang, Y., Zhang, Y., Yao, J., Guo, J., Xu, X., & Wang, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s469110 · Cited by 23
“18 For example, resistance to apoptosis is a common feature of both tumor cells and stem cells.”
BackgroundPharmaceutical Intervention of Aging
Qian, M., & Liu, B. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1117-8_15 · Cited by 19
(2019) · doi:10.1101/609438 · Cited by 15
B cell senescence promotes age‐related changes in oral microbiota
Mizuno, H., Kawamoto, S., Uemura, K., Park, J. H., Hori, N., Okumura, Y., Konishi, Y., & Hara, E. (2024) · Aging Cell · doi:10.1111/acel.14304 · Cited by 19
“…cells, which is often seen with aging and/or obesity (Krishnamurthy et al., 2004 ; López-Otín et al., 2023; Yamakoshi et al., 2009 ; Yoshimoto et al., 2013 ), ultimately leads to harmful side effects (D. J. Baker et al., 2016; Chan & Narita, 2019; Mehdizadeh et al., 2022; Ogrodnik et al., 2017 ).”
Adipose tissue microenvironments during aging: Effects on stimulated lipolysis
Camell, C. D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159118 · Cited by 17
Ageing-associated phenotypes in mice
Xie, K., & Ehninger, D. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111852 · Cited by 14
Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis
Verzola, D., Saio, M., Picciotto, D., Viazzi, F. C., Russo, E., Cipriani, L., Carta, A., Costigliolo, F., Gaggero, G., Salvidio, G., et al. (2020) · American Journal of Nephrology · doi:10.1159/000511560 · Cited by 15
Mocchegiani, E., & Malavolta, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_66 · Cited by 17
Selective Elimination of Senescent Fibroblasts by Targeting the Cell Surface Protein ACKR3
Takaya, K., Asou, T., & Kishi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126531 · Cited by 16
Phosphodiesterase-1 in the cardiovascular system
Roks, A. J. M. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110251 · Cited by 15
Analysis of the senescence‐associated cell surfaceome reveals potential senotherapeutic targets
Deng, Y., Liu, T., Scifo, E., Li, T., Xie, K., Taschler, B., Morsy, S., Schaaf, K., Ehninger, A., Bano, D., et al. (2024) · Aging Cell · doi:10.1111/acel.14312 · Cited by 17
Ho, C. Y., Wu, M., Thammaphet, J., Ahmad, S., James Ho, C. S., Draganova, L., Anderson, G., Jonnalagadda, U. S., Hayward, R., Shroff, R. C., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325374 · Cited by 17
“4,73,74 Our data suggests that capturing or modifying primed cells during presenescence may also be beneficial and that PLA–expressing cells may represent this primed population.”
Mavrogonatou, E., & Kletsas, D. (2024) · Metabolites · doi:10.3390/metabo14030146 · Cited by 18
“…by the studies of Baker et al., in which the use of the transgene INK-ATTAC for inducible elimination of p16 INK4a -positive senescent cells delayed the onset or attenuated the progression of already established age-related phenotypes in several tissues and extended median lifespan in mice [33,34].”
ResultThe Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Jain, S. S., Sojo, G. B., Sun, H., Friedland, B. N., McNamara, M. E., Schmidt, M. O., & Wellstein, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137013 · Cited by 18
Çobanoglu, Ö., Delval, L., Ferrari, D. P., Deruyter, L., Heumel, S., Wolowczuk, I., Hussein, A., Menevse, A. N., Bernard, D., Beckhove, P., et al. (2023) · Aging Cell · doi:10.1111/acel.14007 · Cited by 12
Jin, Y., Kim, E. N., Lim, J. H., Kim, H. D., Ban, T. H., Yang, C. W., Park, C. W., & Choi, B. S. (2021) · Cells · doi:10.3390/cells10102580 · Cited by 16
Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan
Matteini, F., Montserrat‐Vazquez, S., & Florian, M. C. (2024) · FEBS Letters · doi:10.1002/1873-3468.14865 · Cited by 16
Signs of Similarities and Differences in Cellular Models of Aging: A Scoping Review
Васильевна, М. Г., & Khokhlov, A. N. (2022) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392522030087 · Cited by 16
Cortesi, E. E., Meeusen, B., Vanstapel, A., Verleden, S. E., Vanaudenaerde, B. M., Wuyts, W. A., Janssens, W., Janssens, V., Roskams, T., & Ventura, J. (2021) · Cells · doi:10.3390/cells10123437 · Cited by 16
Hou, Q., Li, G., Pan, X., Zhong, X., Geng, X., Yang, X., Yang, X., & Zhang, B. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103670 · Cited by 16
“Senescent cells occur in different tissues of aged animals and contribute to age-associated in fl ammation; their removal extends the health span (Baker et al., 2016; Campisi, 2013).”
BackgroundThe Potent and Paradoxical Biology of Cellular Senescence in Cancer
Romesser, P. B., & Lowe, S. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-124434 · Cited by 16
Elimination of Senescent Endothelial Cells: Good or Bad Idea?
Martin, N., Huna, A., & Bernard, D. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.02.009 · Cited by 15
Unravelling the impact of aging on the human endothelial lncRNA transcriptome
Drekolia, M.-K., Talyan, S., Emídio, R. C., Boon, R. A., Günther, S., Looso, M., Dumbović, G., & Bibli, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1035380 · Cited by 14
“Notably, the elimination of senescent cells (senolysis) was recently reported to improve normal and pathological changes associated with aging in mice (Baker et al., 2016; Xu et al., 2018) and the recent development of endothelial cell-specific senolytic targeting seno-antigens could be a promising strategy for new se…”
BackgroundHow aging causes osteoarthritis: An evolutionary physiology perspective
Gems, D. (2025) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2025.05.001 · Cited by 15
“Particularly striking was the finding that in aging mice elimination of senescent cells delayed onset of many late-life diseases, including cancer, atherosclerosis and kidney disease, and also markedly extended lifespan (Baker et al., 2016; Childs et al., 2016).”
Does Calorie Restriction Modulate Inflammaging via FoxO Transcription Factors?
Kim, S. E., Mori, R., & Shimokawa, I. (2020) · Nutrients · doi:10.3390/nu12071959 · Cited by 15
Bahour, N., Bleichmar, L., Abarca, C., Wilmann, E., Sanjines, S., & Aguayo‐Mazzucato, C. (2023) · Aging · doi:10.18632/aging.204483 · Cited by 16
“INK-ATTAC mice are a transgenic whole-body FLAG-tagged line that allows specific deletion of cells expressing p16 Ink4a upon administration of B/B homodimerizer, a synthetic drug that causes dimerization and activation of the caspase 8 only in p16 Ink4a -positive cells [21, 22].”
Dysregulation of mTORC1/autophagy axis in senescence
Carroll, B., & Korolchuk, V. I. (2017) · Aging · doi:10.18632/aging.101277 · Cited by 13
Zarakowska, E., Czerwińska, J., Tupalska, A., Yousefzadeh, M., Gregg, S. Q., Croix, C. M. S., Niedernhofer, L. J., Foksiński, M., Gackowski, D., Szpila, A., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly012 · Cited by 12
p16INK4a Plays Critical Role in Exacerbating Inflammaging in High Fat Diet Induced Skin
Liang, Y., Gu, T., Peng, S., Lin, Y., Liu, J., Wang, X., Huang, X., Zhang, X., Zhu, J., Zhao, L., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3415528 · Cited by 17
“Clearance of p16 positive senescent cells in mice alleviates the detrimental features of cardiac aging, including myocardial hypertrophy and fibrosis [15].”
Rejuvenating Muscle Stem Cell Function: Restoring Quiescence and Overcoming Senescence
Mendelsohn, A. R., & Larrick, J. W. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1829 · Cited by 14
Drullion, C., Marot, G., Martin, N., Deslé, J., Saas, L., Salazar-Cardozo, C., Bouali, F., Pourtier, A., Abbadie, C., & Pluquet, O. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.008 · Cited by 19
Systems modelling ageing: from single senescent cells to simple multi-cellular models
Guimera, A. M., Welsh, C., Pezze, P. D., Fullard, N., Nelson, G., Roger, M., Przyborski, S. A., & Shanley, D. P. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160087 · Cited by 12
Yang, Y., Duan, C., Huang, L., Xia, X., Zhong, Z., Wang, B., Wang, Y., & Ding, W. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112838 · Cited by 13
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
Guzman, S. D., Judge, J., Shigdar, S. M., Paul, T. A., Davis, C. S., Macpherson, P. C. D., Markworth, J. F., Remmen, H. V., Richardson, A. G., McArdle, A., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2021.821904 · Cited by 16
Zhong, J., Wang, B., Wu, B., Shang, J., Jiang, N., Cui, A., Chen, Y., Xu, X., & Lu, H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119036 · Cited by 13
Self-citationSocial dominance and rainfall predict telomere dynamics in a cooperative arid‐zone bird
Wood, E. M., Capilla‐Lasheras, P., Cram, D. L., Walker, L. A., York, J. E., Lange, A., Hamilton, P. B., Tyler, C. R., & Young, A. J. (2021) · Molecular Ecology · doi:10.1111/mec.15868 · Cited by 17
Photoacoustic polydopamine-indocyanine green (PDA-ICG) nanoprobe for detection of senescent cells
Hartono, M., Baker, A. G., Else, T. R., Evtushenko, A. S., Bohndiek, S. E., Muñoz‐Espín, D., & Fruk, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-79667-7 · Cited by 16
“This is exemplified by the pharmacological eradication of senescent cells (senotherapies) that reduce tumour burden and extends survival 20,22 .”
Cellular uptake and retention studies of silica nanoparticles utilizing senescent fibroblasts
Perrigue, P. M., Henschke, A., Grześkowiak, B. F., Przysiecka, Ł., Jaskot, K., Mielcarek, A., Coy, E. L., & Moya, S. E. (2023) · Scientific Reports · doi:10.1038/s41598-022-26979-1 · Cited by 16
Sharma, G., Banerjee, R., & Srivastava, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c07480 · Cited by 14
Targeting aging cells improves survival
Cox, L. S., & Lord, J. M. (2021) · Science · doi:10.1126/science.abi4474 · Cited by 13
Zwi‐Dantsis, L., Jayarajan, V., Church, G. M., Kamm, R. D., de Magalhães, J. P., & Moeendarbary, E. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500217 · Cited by 16
Mitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
The eroding chromatin landscape of aging stem cells
Shi, C., Wang, L., & Sen, P. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.08.002 · Cited by 17
Fang, X., Huang, E., Xie, X., Yang, K., Wang, S., Huang, X., & Song, M. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.951311 · Cited by 12
“When senescent cells (expressing p16INK4a) were pharmacologically eliminated in aging mice, the incidence of spontaneous tumorigenesis and cancer-related death was reduced (Baker et al., 2016).”
BackgroundA novel suicide gene therapy for the treatment of p16Ink4a-overexpressing tumors
Kohli, J. S., Campisi, J., & Demaria, M. (2017) · Oncotarget · doi:10.18632/oncotarget.23752 · Cited by 14
Cellular senescence and cell therapy in cardiovascular diseases
Chang, D., Wang, J., Zhu, S., Shentu, Y., Wang, Y., Zhu, P., & Ōno, M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04731-6 · Cited by 15
Bramwell, L. R., & Harries, L. W. (2023) · GeroScience · doi:10.1007/s11357-023-00933-z · Cited by 14
“This is exemplified by observations that targeted depletion of senescent cells leads to increases in multiple healthspan and lifespan-related parameters in animal ageing/progeria models [14–16].”
BackgroundFrom bench to bedside: The critical need for standardized senescence detection
Shah, J., Al-Hashimi, A., Benedetto, M., & Ruchaya, P. J. (2025) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.12.008 · Cited by 13
Barnes, P. J. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.04.001 · Cited by 15
Fraile‐Μartinez, O., León-Oliva, D. D., Boaru, D. L., Castro-Martinez, P. D., Montero, C. G., Barrena-Blázquez, S., García-García, J., García‐Honduvilla, N., Álvarez‐Mon, M., López-González, L., et al. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1345459 · Cited by 17
Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence
Daigh, L. H., Saha, D., Rosenthal, D. L., Ferrick, K. R., & Meyer, T. (2024) · Nature Communications · doi:10.1038/s41467-024-52820-6 · Cited by 19
“The role of p16 in triggering senescence is relevant in vivo since expression of the tumor suppressor p16 is a molecular hallmark of senescent cells 2,23 and p16-positive senescent cells play a causative role in multiple aging-associated phenotypes 24,25 .”
Telomere Interacting Proteins and TERRA Regulation
Pérez‐Martínez, L., Wagner, T., & Luke, B. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.872636 · Cited by 13
A new model and precious tool to study molecular mechanisms of macrophage aging
Smith, R., Bassand, K., Dussol, A., Piesse, C., Duplus, E., & Hadri, K. E. (2024) · Aging · doi:10.18632/aging.206124 · Cited by 21
Iron retardation in lysosome protects senescent cells from ferroptosis
Feng, Y., Wei, H., Lyu, M., Yu, Z., Chen, J., Lyu, X., & Zhuang, F. (2024) · Aging · doi:10.18632/aging.205777 · Cited by 34
Bang, E., Lee, B., Noh, S., Kim, D. H., Jung, H. J., Ha, S., Yu, B. P., & Chung, H. Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.301 · Cited by 12
Wang, H., Gao, Y., Mingzhang, Dai, G.-C., Lu, P., Li, Y., Cao, M., Liu, X., Sheng, R., Shi, L., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.013 · Cited by 19
An antibiotic that mediates immune destruction of senescent cancer cells
Raffi, G. C., Chen, J., Feng, X., Chen, Z., Lieftink, C., Deng, S., Mo, J., Zeng, C., Steur, M., Wang, J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417724121 · Cited by 18
Cellular Senescence in Health, Disease and Aging: Blessing or Curse?
Rießland, M. (2021) · Life · doi:10.3390/life11060541 · Cited by 12
Mitochondria‐Targeting Plasmonic Spiky Nanorods Increase the Elimination of Aging Cells in Vivo
Lu, M., Qu, A., Li, S., Sun, M., Xu, L., Kuang, H., & Xu, C. (2020) · Angewandte Chemie · doi:10.1002/ange.202002576 · Cited by 13
Stromal senescence contributes to age-related increases in cancer
Ye, J., Melam, A., & Stewart, S. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00840-9 · Cited by 18
The Effects of IL-1β on Astrocytes are Conveyed by Extracellular Vesicles and Influenced by Age
Willis, C. M., Sutter, P. A., Rouillard, M. E., & Crocker, S. J. (2020) · Neurochemical Research · doi:10.1007/s11064-019-02937-8 · Cited by 13
The effects of macronutrients metabolism on cellular and organismal aging
Nehme, J., Altulea, A., Gheorghe, T., & Demaria, M. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.02.005 · Cited by 16
“[12] Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, et al.”
BackgroundHu, G., Zhou, H., Yuan, Z., & Wang, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116916 · Cited by 17
Cellular senescence and tumor promotion: Role of the Unfolded Protein Response
Pluquet, O., & Abbadie, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.001 · Cited by 13
Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases
Tachikart, Y., Malaise, O., Mumme, M., Jørgensen, C., & Brondello, J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.017 · Cited by 12
Circadian rhythm, hypoxia, and cellular senescence: From molecular mechanisms to targeted strategies
Nie, T., Nepovimová, E., & Wu, Q. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177290 · Cited by 13
Treating Age-Related Diseases with Somatic Stem Cells
Brooks, R. W., & Robbins, P. D. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-74470-4_3 · Cited by 14
Senescence marker p16INK4a expression in patients with multiple sclerosis
Yang, J. H., Miner, A. E., Fair, A. E., Kinkel, R. P., & Graves, J. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105498 · Cited by 13
Modelling the dynamics of senescence spread
Martin, L., Schumacher, L. J., & Chandra, T. (2023) · Aging Cell · doi:10.1111/acel.13892 · Cited by 11
“However, multiple lines of evidence suggest that an accumulation of senescent cells and uncontrolled spread will ultimately lead to tissue dysfunction (Baker et al., 2016; Baker et al., 2011; Burd et al., 2013; Katzir et al., 2021).”
BackgroundDoan, L., Paine, P., Tran, C., Parsons, B., Hiller, A., Joshua, I., Collaco, N., Vitari, A., de Morrée, A., Ishak, H. D., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-92962/v1 · Cited by 16
NAD + , Senolytics, or Pyruvate for Healthy Aging?
Zhou, F. (2021) · Nutrition and Metabolic Insights · doi:10.1177/11786388211053407 · Cited by 15
Neutrophil extracellular traps as therapeutics target in vascular aging
Mao, J., Wu, S., Yan, Z.-L., Huang, G., & Yu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1657938 · Cited by 13
A murine aging cell atlas reveals cell identity and tissue-specific trajectories of aging
(2019) · doi:10.1101/657726 · Cited by 12
Cellular Senescence Exacerbates Features of Aging in the Eyes
Kitazawa, K., Campisi, J., Numa, K., Patel, S. K., King, C. D., Matsumoto, A., Sotozono, C., Desprez, P., & Schilling, B. (2023) · doi:10.59368/agingbio.20230014 · Cited by 14
Wu, J., Liu, X., Liu, Y., Su, W., & Zhuo, Y. (2025) · Bioengineering · doi:10.3390/bioengineering12060563 · Cited by 15
Myofibroblast senescence promotes arrhythmogenic remodeling in the aged infarcted rabbit heart
Baggett, B., Murphy, K. R., Sengun, E., Mi, E., Cao, Y., Turan, N. N., Lu, Y., Schofield, L., Kim, T. Y., Kabakov, A. Y., et al. (2023) · eLife · doi:10.7554/elife.84088 · Cited by 13
Yamaguchi, Y., Zampino, M., Tanaka, T., Bandinelli, S., Osawa, Y., Ferrucci, L., & Semba, R. D. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa324 · Cited by 13
Nadeau, S., Cheng, A., Colmegna, I., & Rodier, F. (2019) · Methods in molecular biology · doi:10.1007/7651_2019_217 · Cited by 13
Chandra, A., Law, S. F., & Pignolo, R. J. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112059 · Cited by 13
Qiu, G., Zheng, X., Fu, M., Huang, C., & Yang, X. (2019) · Biogerontology · doi:10.1007/s10522-019-09832-3 · Cited by 14
Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models
Inci, N., Kamali, D., Akyildiz, E. O., Tahir Turanli, E., & Bozaykut, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.828058 · Cited by 13
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.